Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder

Author(s): Ying Tong, Li Wang, Kai Liu, Weishi Liu, Shen Li, Bo Song, Zongping Xia, Yuming Xu and Rui Zhang*

Volume 18, Issue 2, 2021

Published on: 02 July, 2021

Page: [227 - 236] Pages: 10

DOI: 10.2174/1567202618666210702113526

Price: $65

Abstract

Objective: To investigate the factors related to the prognosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) in cerebrospinal fluid and peripheral blood examination.

Methods: In this study, we enrolled 111 patients who were admitted to the First Affiliated Hospital of Zhengzhou University between January 2016 and January 2018 and diagnosed with NMOSD. The patients were divided into the relapse group (n = 48) and remission group (n = 67). Before treatment, all the patients underwent a routine Cerebrospinal Fluid (CSF) and peripheral blood test on the second morning of admission. The association between laboratory data and disease prognosis was evaluated.

Results: The immunoglobulin G (IgG) level in the serum showed a strong correlation with the relapse of patients, especially in the aquaporin-4-Antibody (AQP4-Ab) positive group (p < 0.01). A high level of serum IgG concentration was associated with the relapse of NMOSD, especially in the anti-AQP4 positive group. The area under the Receiver Operating Characteristic (ROC) curve of serum IgG level was 0.888 (p<0.001, 95%CI: 0.808-0.968). The ratio of Neutrophils to Lymphocytes (NLR) was associated with the disability degree of NMOSD patients in 3 years. The NLR value was a linear correlation with final Expanded Disability Status Scale (EDSS) scores; patients with a high level of NLR value presented an increased degree of disability in the following three years (R2 = 0.053, p= 0.015).

Conclusion: The serum IgG level and NLR of first-attack patients were correlated with the prognosis of NMOSD.

Keywords: Immunoglobulin G, neutrophils, lymphocytes, neuromyelitis optica spectrum disorder, prognosis, the expanded disability status scale, aquaporin-4.

« Previous Next »
[1]
Paul S, Mondal GP, Bhattacharyya R, Ghosh KC, Bhat IA. Neuromyelitis optica spectrum disorders. J Neurol Sci 2021; 420: 117225.
[http://dx.doi.org/10.1016/j.jns.2020.117225] [PMID: 33272591]
[2]
Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85(2): 177-89.
[http://dx.doi.org/10.1212/WNL.0000000000001729] [PMID: 26092914]
[3]
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202(4): 473-7.
[http://dx.doi.org/10.1084/jem.20050304] [PMID: 16087714]
[4]
Palace J, Lin D-Y, Zeng D, et al. Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders. Brain 2019; 142(5): 1310-23.
[http://dx.doi.org/10.1093/brain/awz054] [PMID: 30938427]
[5]
Akaishi T, Takahashi T, Fujihara K, et al. Risk factors of attacks in neuromyelitis optica spectrum disorders. J Neuroimmunol 2020; 343: 577236.
[http://dx.doi.org/10.1016/j.jneuroim.2020.577236] [PMID: 32279020]
[6]
Fan R, Zhang Y, Xu Y, et al. Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder. Brain Behav 2021; 11(1): e01865.
[http://dx.doi.org/10.1002/brb3.1865] [PMID: 33319460]
[7]
Cobo-Calvo A, Ruiz A, Richard C, et al. Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability. PLoS One 2020; 15(9): e0238301.
[http://dx.doi.org/10.1371/journal.pone.0238301] [PMID: 32881954]
[8]
Ramakrishnan P, Nagarajan D. Neuromyelitis optica spectrum disorder: An overview. Acta Neurobiol Exp (Warsz) 2020; 80(3): 256-72.
[http://dx.doi.org/10.21307/ane-2020-023] [PMID: 32990284]
[9]
Kleerekooper I, Herbert MK, Kuiperij HB, et al. CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD. J Neurol Neurosurg Psychiatry 2020; 91(6): 605-11.
[http://dx.doi.org/10.1136/jnnp-2019-322286] [PMID: 32217788]
[10]
Chang X, Huang W, Wang L, et al. Serum neurofilament light and GFAP are associated with disease severity in inflammatory disorders with aquaporin-4 or myelin oligodendrocyte glycoprotein antibodies. Front Immunol 2021; 12: 647618.
[http://dx.doi.org/10.3389/fimmu.2021.647618] [PMID: 33796113]
[11]
Hyun JW, Kim Y, Kim SY, Lee MY, Kim SH, Kim HJ. Investigating the presence of interattack astrocyte damage in neuromyelitis optica spectrum disorder: Longitudinal analysis of serum glial fibrillary acidic protein. Neurol Neuroimmunol Neuroinflamm 2021; 8(3): e965.
[http://dx.doi.org/10.1212/NXI.0000000000000965] [PMID: 33846219]
[12]
Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 2012; 135(Pt 6): 1834-49.
[http://dx.doi.org/10.1093/brain/aws109] [PMID: 22577216]
[13]
Huang W, ZhangBao J, Chang X, et al. Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience. Mult Scler Relat Disord 2020; 46: 102542.
[http://dx.doi.org/10.1016/j.msard.2020.102542] [PMID: 33296965]
[14]
Demirci S, Demirci S, Kutluhan S, Koyuncuoglu HR, Yurekli VA. The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis. Int J Neurosci 2016; 126(8): 700-6.
[PMID: 26000934]
[15]
Bawa KK, Krance SH, Herrmann N, et al. A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease. J Neuroinflammation 2020; 17(1): 84.
[http://dx.doi.org/10.1186/s12974-020-01750-3] [PMID: 32171317]
[16]
Akıl E, Bulut A, Kaplan İ, Özdemir HH, Arslan D, Aluçlu MU. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease. Neurol Sci 2015; 36(3): 423-8.
[http://dx.doi.org/10.1007/s10072-014-1976-1] [PMID: 25288159]
[17]
Liu YL, Wu ZQ, Qu JF, et al. High neutrophil-to-lymphocyte ratio is a predictor of poor short-term outcome in patients with mild acute ischemic stroke receiving intravenous thrombolysis. Brain Behav 2020; 10(12): e01857.
[http://dx.doi.org/10.1002/brb3.1857] [PMID: 32981201]
[18]
Benetou C, Berti F, Hemingway C, Hacohen Y, Lim M. Neutrophil-to-lymphocyte ratio correlates with disease activity in myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) in children. Mult Scler Relat Disord 2020; 45: 102345.
[http://dx.doi.org/10.1016/j.msard.2020.102345] [PMID: 32653734]
[19]
Bisgaard AK, Pihl-Jensen G, Frederiksen JL. The neutrophil-to- lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis. Mult Scler Relat Disord 2017; 18: 213-7.
[http://dx.doi.org/10.1016/j.msard.2017.10.009] [PMID: 29141813]
[20]
Naegele M, Tillack K, Reinhardt S, Schippling S, Martin R, Sospedra M. Neutrophils in multiple sclerosis are characterized by a primed phenotype. J Neuroimmunol 2012; 242(1-2): 60-71.
[http://dx.doi.org/10.1016/j.jneuroim.2011.11.009] [PMID: 22169406]
[21]
Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162-73.
[http://dx.doi.org/10.1016/S1474-4422 (17)30470-2] [PMID: 29275977]
[22]
Bukhari W, Clarke L, O’Gorman C, et al. The clinical profile of NMOSD in Australia and New Zealand. J Neurol 2020; 267(5): 1431-43.
[http://dx.doi.org/10.1007/s00415-020-09716-4] [PMID: 32006158]
[23]
Kronimus Y, Dodel R, Galuska SP, Neumann S. IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target? J Autoimmun 2019; 96: 14-23.
[http://dx.doi.org/10.1016/j.jaut.2018.10.006] [PMID: 30360925]
[24]
Jarius S, Franciotta D, Paul F, et al. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: Frequency, origin, and diagnostic relevance. J Neuroinflammation 2010; 7: 52.
[http://dx.doi.org/10.1186/1742-2094-7-52] [PMID: 20825655]
[25]
Wang Y, Zhu M, Liu C, et al. Blood brain barrier permeability could be a biomarker to predict severity of neuromyelitis optica spectrum disorders: A retrospective analysis. Front Neurol 2018; 9: 648.
[http://dx.doi.org/10.3389/fneur.2018.00648] [PMID: 30131763]
[26]
Jarius S, Paul F, Franciotta D, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures. J Neurol Sci 2011; 306(1-2): 82-90.
[http://dx.doi.org/10.1016/j.jns.2011.03.038] [PMID: 21550068]
[27]
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66(10): 1485-9.
[http://dx.doi.org/10.1212/01.wnl.0000216139.44259.74] [PMID: 16717206]
[28]
Tugizova M, Vlahovic L, Tomczak A, Wetzel NS, Han MH. New therapeutic landscape in neuromyelitis optica. Curr Treat Options Neurol 2021; 23(4): 13.
[http://dx.doi.org/10.1007/s11940-021-00667-3] [PMID: 33814893]
[29]
Gurbuz O, Kumtepe G, Ozkan H, et al. Predictive value of neutrophil-lymphocyte ratio for long-term cardiovascular event following coronary artery bypass grafting. Rev Bras Cir Cardiovasc 2020; 35(3): 274-84.
[http://dx.doi.org/10.21470/1678-9741-2018-0362] [PMID: 32549098]
[30]
Korkmaz C, Demircioglu S. The association of neutrophil/lymphocyte and platelet/lymphocyte ratios and hematological parameters with diagnosis, stages, extrapulmonary involvement, pulmonary hypertension, response to treatment, and prognosis in patients with sarcoidosis. Can Respir J 2020; 2020: 1696450.
[http://dx.doi.org/10.1155/2020/1696450] [PMID: 33062080]
[31]
An İ, Aksoy M, Ayhan E, Ozturk M. The effect of secukinumab treatment on inflammatory parameters in patients with psoriasis: A multicentre restrospective study. Int J Clin Pract 2021; 2021: e14114.
[PMID: 33626203]
[32]
Zou G, Gao H. The relationship between neutrophil-lymphocyte ratio and early renal fibrosis and renal prognosis in patients with lupus nephritis. Am J Transl Res 2021; 13(3): 1710-6.
[PMID: 33841693]
[33]
Liu Z, Ge H, Miao Z, Shao S, Shi H, Dong C. Dynamic changes in the systemic inflammation response index predict the outcome of resectable gastric cancer patients. Front Oncol 2021; 11: 577043.
[http://dx.doi.org/10.3389/fonc.2021.577043] [PMID: 33718137]
[34]
Lin J, Xue B, Li J, et al. Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD. Neurol Sci 2017; 38(10): 1859-63.
[http://dx.doi.org/10.1007/s10072-017-3068-5] [PMID: 28779361]
[35]
Carnero Contentti E, Delgado-García G, Criniti J, et al. An abnormally high neutrophil-to-lymphocyte ratio is not an independent outcome predictor in AQP4-IgG-Positive NMOSD. Front Immunol 2021; 12: 628024.
[http://dx.doi.org/10.3389/fimmu.2021.628024] [PMID: 33717149]
[36]
Piatek P, Domowicz M, Lewkowicz N, et al. C5a-preactivated neutrophils are critical for autoimmune-induced astrocyte dysregulation in neuromyelitis optica spectrum disorder. Front Immunol 2018; 9: 1694.
[http://dx.doi.org/10.3389/fimmu.2018.01694] [PMID: 30083159]
[37]
Chen T, Bosco DB, Ying Y, Tian DS, Wu LJ. The emerging role of microglia in neuromyelitis optica. Front Immunol 2021; 12: 616301.
[http://dx.doi.org/10.3389/fimmu.2021.616301] [PMID: 33679755]
[38]
Kim S-M, Waters P, Woodhall M, et al. Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G. Mult Scler 2017; 23(8): 1104-11.
[http://dx.doi.org/10.1177/1352458516674366] [PMID: 27760862]
[39]
Marignier R, Bernard-Valnet R, Giraudon P, et al. Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity. Neurology 2013; 80(24): 2194-200.
[http://dx.doi.org/10.1212/WNL.0b013e318296e917] [PMID: 23658379]
[40]
Yao XY, Wu YF, Gao MC, et al. Serum albumin level is associated with the severity of neurological dysfunction of NMOSD patients. Mult Scler Relat Disord 2020; 43: 102130.
[http://dx.doi.org/10.1016/j.msard.2020.102130] [PMID: 32417662]

Rights & Permissions Print Cite
Article Metrics
33
1
© 2024 Bentham Science Publishers | Privacy Policy